UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 110

Sortiert nach

An evolutionary perspective on chronic myelomonocytic leukemia

Leukemia, 2013-07, Vol.27 (7), p.1441-1450

2013

Link zum Volltext

Verfügbarkeit prüfen

Epigenetics of myelodysplastic syndromes

Leukemia, 2014-03, Vol.28 (3), p.497-506

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias

Leukemia, 2011-07, Vol.25 (7), p.1147-1152

2011

Link zum Volltext

Verfügbarkeit prüfen

ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients

Leukemia, 2014-11, Vol.28 (11), p.2206-2212

2014

Link zum Volltext

Verfügbarkeit prüfen

CLINICAL MANAGEMENT OF CMML

Leukemia research, 2023-05, Vol.128, p.107109, Article 107109

Itzykson, R.

2023

Link zum Volltext

Verfügbarkeit prüfen

Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis

Cell, 2004-06, Vol.117 (7), p.927-939

2004

Link zum Volltext

Verfügbarkeit prüfen

SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias

Leukemia, 2013-06, Vol.27 (6), p.1401-1403

2013

Link zum Volltext

Verfügbarkeit prüfen

S168: ERYTHROPOIETIN STIMULATION AGENTS SIGNIFICANTLY IMPROVES OUTCOME IN LOWER RISK MDS

HemaSphere, 2022-06, Vol.6, p.69-70

2022

Link zum Volltext

Verfügbarkeit prüfen

An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies

Blood cancer journal (New York), 2015-07, Vol.5 (7), p.e333-e333

2015

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality

Leukemia, 2021-03, Vol.35 (3), p.934-934

2021

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality

Leukemia, 2021-01, Vol.35 (1), p.225-228

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents

Leukemia, 2013-06, Vol.27 (6), p.1283-1290

2013

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of monocyte subset distribution in chronic myelomonocytic leukemia: results of a multicenter study

Leukemia, 2021-03, Vol.35 (3), p.893-896

2021

Link zum Volltext

Verfügbarkeit prüfen

Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia

Leukemia, 2013-09, Vol.27 (9), p.1946-1949

2013

Link zum Volltext

Verfügbarkeit prüfen

Effects of azacitidine in 93 patients with IDH1/2 mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study

Leukemia & lymphoma, 2021-02, Vol.62 (2), p.438-445

2021

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine

Leukemia, 2011-07, Vol.25 (7), p.1207-1209

2011

Link zum Volltext

Verfügbarkeit prüfen

P374: BLINATUMOMAB AS CONSOLIDATION FOR ADULT B‐CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA. A REAL‐WORLD STUDY

HemaSphere, 2022-06, Vol.6, p.274-275

2022

Link zum Volltext

Verfügbarkeit prüfen

Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome

Blood cancer journal (New York), 2015-01, Vol.5 (1), p.e270-e270

2015

Link zum Volltext

Verfügbarkeit prüfen

Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome

Blood cancer journal (New York), 2015-02, Vol.5 (2), p.e280-e280

2015

Link zum Volltext

Verfügbarkeit prüfen

A Retrospective Validation of International Consortium for MDS/MPN Response Criteria in CMML Treated with Hypomethylating Agents

Leukemia research, 2017-04, Vol.55, p.S30-S31

2017

Link zum Volltext

Verfügbarkeit prüfen

Azacitidine Improves Outcome in High Risk MDS Patients with Chromosome 7 Abnormalities: Retrospective Comparison of GESMD and GFM Registries

Leukemia research, 2017-04, Vol.55, p.S61-S63

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of Red Blood Cell Transfusions on Survival in Lower-Risk MDS Patients Included in the European Leukemianet MDS (EUMDS) Registry

LEUKEMIA RESEARCH, 2017, Vol.55, p.S160-S161

2017

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Value of Early Drop in Platelets in Lower-Risk MDS. A Sub-Study from the European Leukemianet Lower-Risk MDS (EUMDS) Registry

LEUKEMIA RESEARCH, 2017, Vol.55, p.S10-S11

2017

Link zum Volltext

Verfügbarkeit prüfen

Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents

Blood cancer journal (New York), 2017-05, Vol.7 (5), p.e562-e562

2017

Link zum Volltext

Verfügbarkeit prüfen

23 DOWN-REGULATION OF MIR150 PROMOTES THE ACCUMULATION OF CLASSICAL MONOCYTES, A CHARACTERISTIC FEATURE OF CHRONIC MYELOMONOCYTIC LEUKEMIA

Leukemia research, 2015-04, Vol.39, p.S10-S10

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(102)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(42)
Humans
(40)
Hematology
(38)
Female
(24)
Male
(23)
Oncology
(23)
Aged
(22)
Middle Aged
(21)
Hematology, Oncology And Palliative Medicine
(20)
Adult
(17)
Medicin Och Hälsovetenskap
(15)
Aged, 80 And Over
(14)
Treatment Outcome
(14)
Leukemia
(13)
Mutation
(13)
Myelodysplastic Syndromes
(12)
Prognosis
(11)
Retrospective Studies
(11)
Acute Myeloid Leukemia
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Leukemia Research
(27)
Blood
(17)
Leukemia
(15)
Haematologica
(7)
Blood Cancer Journal
(5)
Physical Review. D, Particles And Fields
(5)
Hemasphere
(4)
Blood Advances
(3)
Leukemia & Lymphoma
(3)
Hématologie
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An evolutionary perspective on chronic myelomonocytic leukemia

Epigenetics of myelodysplastic syndromes

Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias

ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients

CLINICAL MANAGEMENT OF CMML

Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis

SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias

S168: ERYTHROPOIETIN STIMULATION AGENTS SIGNIFICANTLY IMPROVES OUTCOME IN LOWER RISK MDS

An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies

Correction to: Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality

Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality

Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents

Prognostic value of monocyte subset distribution in chronic myelomonocytic leukemia: results of a multicenter study

Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia

Effects of azacitidine in 93 patients with IDH1/2 mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study

Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine

P374: BLINATUMOMAB AS CONSOLIDATION FOR ADULT B‐CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA. A REAL‐WORLD STUDY

Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome

Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome

A Retrospective Validation of International Consortium for MDS/MPN Response Criteria in CMML Treated with Hypomethylating Agents

Azacitidine Improves Outcome in High Risk MDS Patients with Chromosome 7 Abnormalities: Retrospective Comparison of GESMD and GFM Registries

Impact of Red Blood Cell Transfusions on Survival in Lower-Risk MDS Patients Included in the European Leukemianet MDS (EUMDS) Registry

Prognostic Value of Early Drop in Platelets in Lower-Risk MDS. A Sub-Study from the European Leukemianet Lower-Risk MDS (EUMDS) Registry

Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents

23 DOWN-REGULATION OF MIR150 PROMOTES THE ACCUMULATION OF CLASSICAL MONOCYTES, A CHARACTERISTIC FEATURE OF CHRONIC MYELOMONOCYTIC LEUKEMIA

Suchergebnisse filtern